Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
488 studies found for:    "Sickle cell anemia"
Show Display Options
Rank Status Study
1 Completed Hydroxyurea in Young Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: hydroxyurea
2 Completed Exercise Capacity in Pediatric Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention:
3 Recruiting Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention:
4 Completed The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Paludrine + Folic Acid;   Dietary Supplement: Paludrine + Folic Acid + Jobelyn
5 Completed Adherence to Hydroxyurea in Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Behavioral: Blood smear education;   Other: standard education
6 Not yet recruiting Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Ilaris, Canakinumab;   Drug: Placebo
7 Completed Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
8 Suspended Study of Beet Juice for Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: beet juice (Unbeetable)
9 Completed Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Hydroxyurea;   Drug: L-Arginine;   Drug: Sildenafil
10 Completed Sickle Cell Disease: A Retrospective Chart Review
Condition: Sickle Cell Anemia
Intervention:
11 Completed Carbon Monoxide Measurement to Screen for Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Device: End-tidal Carbon Monoxide Subjects;   Device: End-tidal Carbon Monoxide Controls
12 Terminated Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
13 Recruiting A Phase II Trial of Regadenoson in Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Regadenoson;   Drug: Placebo
14 Completed Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Dietary Supplement: Gum Arabic
15 Completed Study of Ventilatory Mechanics in Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention:
16 Completed Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
17 Recruiting SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Hydroxyurea;   Procedure: TCD examination
18 Recruiting Microvascular Blood Flow in Sickle Cell Anemia
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Interventions: Drug: regadenoson infusion with contrast-enhanced ultrasound;   Procedure: contrast-enhanced ultrasound
19 Completed
Has Results
Prasugrel Versus Placebo in Adult Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Drug: Prasugrel;   Drug: Placebo
20 Completed A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Interventions: Drug: Low Dose ICA-17043;   Drug: High dose ICA-17043;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.